New-onset of vitiligo in a child following COVID-19 vaccination

Since January 2020, the ongoing COVID-19 pandemic has been a global health emergency. Vaccination is a critical measure for containing the spread of COVID-19. At the end of 2020, several vaccines became available. Multiple adverse events (AEs) have been reported with all the available COVID-19 vaccines. This report describes a case of vitiligo in a child that started 2 weeks after COVID-19 messenger RNA (mRNA) vaccine administration.